US Material Events SEC 8-K Filings — July 08, 2026

08-07-2026

Ivanhoe Electric Inc. entered into an Amended and Restated Shareholders Agreement with Saudi Arabian Mining Company (Maaden) on July 7, 2026, governing their 50/50 joint venture in Saudi Arabia. The new agreement extends the exploration term to July 6, 2033 (from an initial five-year term), allows the joint venture to acquire exploration and mining licenses directly, and grants the technical committee more authority. However, the agreement also imposes a non-compete clause on Ivanhoe Electric in Saudi Arabia without Maaden's consent, and Maaden retains significant governance rights including the ability to nominate a director to Ivanhoe Electric's board.

• · The joint venture board chairperson will be chosen from among Maaden's nominees.
• · Maaden will assume operatorship if an economically viable deposit is found and designated for development.
• · If Ivanhoe Electric chooses not to participate in a Designated Project, it may engage Maaden in discussions regarding transfer or exchange of its interest for fair market value, possibly including a royalty.
• · The joint venture is not terminable by either party before the end of the exploration phase except upon an event of default.
• · Upon termination, Typhoon™ units will be returned to Ivanhoe Electric, but Maaden has the right to negotiate continued services for exploring other Maaden land.
• · Maaden beneficially owns greater than 5% of Ivanhoe Electric's common stock and has the right to nominate one director to Ivanhoe Electric's board.

08-07-2026

Newton Golf Company, Inc. (NWTG) entered into a Loan and Security Agreement with Brynwood, LLLP for a senior secured revolving credit facility of up to $5.0M with Daily Simple SOFR plus 13% interest, maturing on an unstated date. The agreement allows semi-annual interest payments and includes a 2% commitment fee, but carries a steep default rate of 22%, reflecting high financing costs for the borrower.

• · Borrower must provide an unconditional promise to pay principal and accrued interest.
• · Advances are subject to a minimum of $200,000 per borrowing.
• · Repayment and reborrowing are allowed during the availability period with no prepayment penalty.
• · Borrower may permanently reduce the commitment in increments of at least $250,000.
• · Interest is computed on a 360-day year for actual days elapsed.
• · A 2% commitment fee ($100,000) is due on the effective date or deducted from the initial advance.
• · Borrower grants a continuing security interest in all collateral, now owned or later acquired.
• · Borrower must pay all Lender expenses, including enforcement costs after an event of default.
• · Any borrowing request constitutes a release of claims against Lender existing prior to that request.
• · Conditions precedent include delivery of organizational documents, UCC searches, and no existing default.
• · The Maturity Date and Availability Period are not specified in the excerpt.

08-07-2026

Spectral AI, Inc. announced the hiring of Darcy L. Bajko as Chief Commercial Officer, effective July 31, 2026, with an annual salary of $315,000 and eligibility for a discretionary bonus of up to 30% of salary. The offer also includes a 401(k) match and an option grant of 150,000 common shares vesting over three years. No departures or financial results were disclosed; the filing solely covers a new executive appointment.

• · Start date of new CCO is July 31, 2026, pending background check.
• · Payroll is processed on the 3rd and 20th of each month.
• · 401(k) plan eligibility begins after three months of employment with dollar-for-dollar match up to 6% of base salary.
• · Option grant of 150,000 common shares vests annually over three years; pricing set on date of Board approval.
• · Paid time off accrues at 10 hours per month (15 days annually) with only 120 hours carryover per year.
• · Employment is at-will; either party may terminate at any time without notice or severance.
• · Confidentiality, non-compete, and proprietary rights agreement (Exhibit A) is attached and must be executed as a condition of employment.

08-07-2026

On July 1, 2026, Alliance Resource Partners, L.P. (ARLP) through its wholly owned subsidiary Matrix Design Africa (PTY) LTD entered into a Master Supply, Distribution and Services Agreement with Saminco Solutions LLC, a company affiliated with ARLP’s President and CEO, Joseph W. Craft III, who beneficially owns approximately 14.6% of ARLP's common units. The agreement grants distribution rights for certain products in Africa and other non-U.S. territories, allows product purchases and services, and includes a five-year initial term with automatic one-year renewals. The related-party transaction was reviewed and approved by the Conflicts Committee of the Board, which determined it to be fair and reasonable to ARLP and its unitholders. No financial terms or quantitative amounts were disclosed in this filing.

• · The Supplier, Saminco Solutions LLC, is affiliated with Joseph W. Craft III, who is also the President and CEO of ARLP's managing general partner and beneficially owns about 14.6% of ARLP's common units.
• · The agreement allows the Customer to serve as non-exclusive distributor in Africa and other non-U.S. territories for Supplier's products, and purchase products and services (including repair/refurbishment).
• · The Supplier also has a non-obligatory right to purchase products from the Customer for incorporation into its own products for resale.
• · Prices for products and services must be no less favorable to the Customer than those extended to similarly situated customers of the Supplier.
• · The agreement may be terminated without cause by either party upon at least 90 days' notice; the Customer can cancel purchase orders under certain circumstances including Supplier non-performance.

08-07-2026

NioCorp Developments Ltd. adopted a formal annual incentive program (AIP) on July 2, 2026, and approved fiscal 2026 AIP payouts for named executive officers, including CEO Mark A. Smith ($602,784), CFO Neal S. Shah ($345,621), and COO Scott Honan ($378,197). The AIP is designed to attract, retain, and align employee interests with shareholders as the company advances its Elk Creek Project. Notably, no cash bonuses were paid to named executive officers for fiscal 2025, highlighting a shift to a performance-based compensation structure.

• · The AIP was adopted on recommendation of the Compensation Committee after a multi-month review with independent consultant Semler Brossy.
• · Award payouts range from 0% to 200% of target based on performance against pre-established measures.
• · For fiscal 2026, performance was weighted 45% corporate milestones, 10% safety, and 45% individual performance.
• · CEO Mark A. Smith's payout is paid to 76 Resources, LLC under a consulting arrangement.
• · No cash bonuses were paid to named executive officers for fiscal 2025.

08-07-2026

Blue Owl Real Estate Net Lease Trust, through affiliates Sunshine Ultimate Parent LLC and Sunshine Holding REIT LLC, has entered into a definitive merger agreement to acquire Sila Realty Trust, Inc. for an undisclosed per-share consideration. The transaction, unanimously approved by Sila's board, will combine the two entities with Sila merging into a subsidiary of Parent. No financial details of the transaction are disclosed in the filing, limiting the ability to assess valuation or performance trends.

• · The merger is structured under Maryland General Corporation Law and Delaware Limited Liability Company Act.
• · Sila Realty Trust's board unanimously approved and recommended the merger to stockholders.
• · Concurrently with the agreement, Parent affiliates provided a limited guarantee to Sila for certain Parent obligations.
• · The definition of 'Company Material Adverse Effect' excludes general market or industry conditions.
• · Sila has outstanding credit facilities from February 2025, March 2024, and May 2022 with Bank of America and Truist Bank.
• · The agreement includes customary provisions regarding no solicitation, termination fees, and access to information.

08-07-2026

HF Sinclair Corporation announced leadership changes, appointing Steven Ledbetter as President and COO and Valerie Pompa as President of Growth, Technology and Transformation. CEO Franklin Myers will continue on a temporary basis, while Matthew Joyce remains in his role reporting directly to the CEO. The changes aim to sharpen execution and drive long-term value creation, but no financial metrics or performance data were provided.

• · Steven Ledbetter previously served as EVP, Commercial since March 2023; prior roles include CEO of Shell Midstream Partners GP LLC and CEO of Jiffy Lube International.
• · Valerie Pompa previously served as EVP, Operations since March 2023; prior roles include SVP, Refining Operations and owner/CEO of VAP Business Solutions Limited.
• · Matthew Joyce will continue as SVP, Lubricants & Specialties, reporting directly to CEO Franklin Myers, as the Lubricants & Specialties segment is considered distinct with its own growth priorities.
• · HF Sinclair operates refineries in Kansas, Oklahoma, New Mexico, Wyoming, Washington, and Utah, and produces renewable diesel at two Wyoming facilities and one New Mexico facility.

08-07-2026

Courtney Mather resigned from the Board of Directors of Caesars Entertainment, Inc. effective July 6, 2026. The resignation was not due to any disagreement with the company. No financial impact or other operational changes were disclosed.

• · Resignation effective July 6, 2026.
• · No disagreement with the company cited as reason for departure.

08-07-2026

Aethlon Medical announced a $4.0 million follow-on offering priced at-the-market under Nasdaq rules, issuing 5,633,009 shares (or pre-funded warrants) and accompanying warrants at $0.7101 per unit. The company intends to use net proceeds for general corporate purposes including R&D, clinical trials, and potential acquisitions. The offering closed on July 7, 2026, but the warrants require stockholder approval before exercisability, introducing execution risk.

• · The warrants have an exercise price of $0.7101 per share, exercisable upon stockholder approval, and expire five years from that date.
• · Maxim Group LLC is the sole placement agent.
• · The offering is made under a Form S-1 registration statement (File No. 333-296933) declared effective on July 6, 2026.
• · The Hemopurifier holds FDA Breakthrough Device designation for advanced/metastatic cancer and life-threatening viruses.

08-07-2026

Ashford Hospitality Trust completed the sale of the 357-room Marriott Fremont Silicon Valley for approximately $52.2 million in net cash proceeds on July 1, 2026. The company used $43.5 million of the proceeds to repay a mortgage loan secured by 14 hotels including the sold property. Pro forma financials show the disposition reduces total hotel revenue by $19.4 million for FY2025 and $5.0 million for Q1 2026, while the company's net loss attributable to common stockholders improves from $215.0 million to $199.3 million for FY2025 and from $71.1 million to $70.6 million for Q1 2026 on a pro forma basis.

• · The mortgage loan repaid was secured by 14 hotels, not just the sold property.
• · Pro forma net loss attributable to common stockholders improves from $215.0M to $199.3M for FY2025 (a $15.7M improvement) and from $71.1M to $70.6M for Q1 2026 (a $0.4M improvement).
• · Pro forma total assets decrease by $47.5M (1.8%) and total liabilities decrease by $45.0M (1.5%) as of March 31, 2026.
• · The company recorded a non-recurring pro forma gain of $13.4M on the disposition for FY2025, which is preliminary and subject to change.
• · The sale reduced hotel operating expenses by $13.7M for FY2025 and $3.1M for Q1 2026 on a pro forma basis.
• · Pro forma earnings per share (basic and diluted) improve from $(35.99) to $(33.35) for FY2025 and from $(11.03) to $(10.97) for Q1 2026.

08-07-2026

On June 2, 2026, Chi Special Acquisition Corp. (formerly Goldenstone Acquisition Ltd.) announced the resignation of directors Pin Tai and Nan Sun and the appointment of Chung Fu Wing and Shangwei Chen to fill the vacancies. The board changes reflect ongoing strategic adjustments at the SPAC, though no financial terms or business combination updates were disclosed.

• · Chi Special Acquisition Corp. is an emerging growth company and a shell company, originally named Goldenstone Acquisition Ltd. (CIK 0001858007).
• · The resignations and appointments were effective June 2, 2026; the 8-K was filed on July 8, 2026.
• · Chung Fu Wing, age 54, has 30 years of experience in multi-asset investment and management consulting, holds an MBA from Columbia Business School and is a CFA Charterholder.
• · Shangwei Chen, age 41, has over 13 years of experience in investment advisory, corporate restructuring, and healthcare management; he is Founder and Managing Partner of SJ Investment.

08-07-2026

Civeo Corporation completed a private offering of $100 million aggregate principal amount of 4.50% Convertible Senior Notes due 2031, receiving net proceeds of approximately $96.2 million. The company used $22.3 million of the proceeds to repurchase 660,297 of its common shares and intends to use the remainder to repay outstanding borrowings under its credit facility. The notes are convertible into common shares at an initial conversion price of approximately $40.51 per share, and the offering was conducted as an unregistered transaction under Rule 144A.

• · The notes bear interest at 4.50% per annum, payable semi-annually on February 1 and August 1, starting February 1, 2027.
• · The notes mature on August 1, 2031, unless earlier repurchased, redeemed, or converted.
• · The company may not redeem the notes prior to August 1, 2029, except for tax or cleanup redemptions.
• · Holders may convert notes under certain conditions, including if the stock price exceeds 130% of the conversion price for 20 trading days in a 30-day period.
• · Upon a fundamental change, holders may require the company to repurchase the notes at 100% of principal plus accrued interest.
• · The indenture includes customary events of default, including delisting events.

08-07-2026

Internet Sciences, Inc. appointed Keith R. Wyche to its Board of Directors effective July 1, 2026. Mr. Wyche brings over two decades of leadership experience from Walmart, Cub Foods, Acme Markets, IBM, Pitney Bowes, and Convergys, and currently serves on the board of The Brink's Company. The appointment was ratified by majority shareholders.

• · Keith R. Wyche is a retired Vice President, Community Engagement and Support at Walmart Inc.
• · He previously served as President of Cub Foods and Acme Markets.
• · He currently serves on the board of The Brink's Company (NYSE: BCO).
• · The appointment was ratified by written consent of the majority shareholders.

08-07-2026

AmpliTech Group, Inc. terminated its Equity Distribution Agreement with Maxim Group LLC effective July 7, 2026, and simultaneously announced a $10 million stock repurchase program authorized by its Board of Directors to be executed over 24 months. The termination of the at-the-market offering agreement removes a potential dilutive capital source, while the buyback program signals management's confidence but is discretionary and non-binding.

• · The Equity Distribution Agreement was originally dated March 21, 2025.
• · The repurchase program may be executed through open market purchases, privately negotiated transactions, block trades, or other means.
• · The company may enter into a trading plan under Rule 10b5-1.
• · The program does not obligate the company to repurchase any specific number of shares and can be suspended, modified, or discontinued at any time without notice.

08-07-2026

Moderna appointed Michael McDonnell, former CFO of Biogen, to its Board of Directors effective July 8, 2026. McDonnell brings over 35 years of financial leadership and public company experience, and will also serve on the Audit Committee. The appointment is a routine governance update with no financial impact disclosed.

• · McDonnell served as EVP and CFO of Biogen from August 2020 through February 2025.
• · Since March 2025, he has been an advisor to Goldman Sachs Asset Management.
• · He currently serves on the boards of Merit Medical Systems (Audit Committee chair) and Baxter International.
• · He began his career at PricewaterhouseCoopers, spending 14 years including four as a partner.

08-07-2026

Ovid Therapeutics announced the departure of Jeffrey Rona as Chief Business and Financial Officer, effective July 6, 2026, and appointed Charles Carter as CFO. The transition was mutual and not due to any disagreement. Carter brings experience from CERo Therapeutics and other life sciences firms, with a compensation package including a $460,000 base salary and equity grants.

• · Charles Carter, age 59, previously served as SVP of Finance at Ovid from October 2024 to July 2026.
• · Carter's prior roles include CFO at CERo Therapeutics (Feb 2024-Sep 2024), where he helped launch the company post de-SPAC.
• · Carter holds a BS from Colgate University and an MBA/MS from University of Chicago.
• · Rona's consulting agreement runs through December 31, 2027, with continued equity vesting during that period.
• · No family relationships or transactions requiring disclosure under Regulation S-K were identified for Carter.

08-07-2026

Aura Biosciences announced the appointment of Jeremy Bender, Ph.D., M.B.A., to its Board of Directors. Dr. Bender brings extensive late-stage development and commercialization experience, having previously led Day One Biopharmaceuticals through its acquisition by Servier for approximately $2.5 billion. The company is advancing its lead candidate bel-sar toward potential regulatory approval for early choroidal melanoma, with enrollment complete in the Phase 3 CoMpass trial.

• · Dr. Bender most recently served as CEO, President, and board member of Day One Biopharmaceuticals, leading its acquisition by Servier for ~$2.5B in 2026.
• · He previously served as Vice President of Corporate Development at Gilead Sciences and held executive roles at Tizona Therapeutics, Sutro Biopharma, and Allos Therapeutics.
• · Dr. Bender currently serves as an independent board member of Mereo BioPharma Group plc and previously served on the board of Fusion Pharmaceuticals.
• · He earned a B.S. from Stanford, a Ph.D. from the University of Colorado, and an M.B.A. from MIT Sloan.
• · Aura's lead candidate bel-sar is in late-stage development for early choroidal melanoma and early-stage development for other ocular oncology indications and bladder cancer.

08-07-2026

AEP Texas, a subsidiary of American Electric Power, has secured a $3.26 billion loan from the U.S. Department of Energy's Office of Energy Dominance Financing to fund nearly 100 grid infrastructure projects. The investment is expected to save customers $685 million over 30 years, support up to 41 GW of new load additions through 2030, and rebuild or reconductor approximately 2,800 miles of transmission lines. This initiative aims to enhance reliability and manage affordability in one of the fastest-growing U.S. regions.

• · AEP Texas is an energy delivery (wires) company operating in the deregulated Texas retail electric marketplace.
• · The loan is part of AEP's broader strategy across its 11-state service territory to secure federal funding to reduce customer costs while supporting growth and investing in reliability and resiliency.
• · AEP Texas also builds new power lines, restores service following outages, reads meters via advanced meter technology, and connects/disconnects service upon orders from retail electric providers.

08-07-2026

Dravica Corp announced executive and board changes effective July 3, 2026: Robert Damian Szubanski resigned as Treasurer, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer (remaining President), and Varinia-Rebecca Undine Marie-Anne Koenig resigned as Secretary (remaining a Board member). Radek Chovanec, age 31, was appointed to fill all those vacated roles plus as a Director, bringing experience as Executive Director of M.B. Trade s.r.o. and a degree in Marketing Communications. The changes represent a consolidation of key officer positions into one individual; no financial metrics were disclosed.

• · Radek Chovanec has served as Executive Director of M.B. Trade s.r.o. since March 8, 2022.
• · Mr. Chovanec earned a degree in Marketing Communications from Tomas Bata University in Zlin, Czech Republic.
• · No family relationships, material transactions, or arrangements leading to Mr. Chovanec’s appointment were reported.
• · The company is an emerging growth company and has elected not to use the extended transition period for new accounting standards.

08-07-2026

Power REIT appointed Brent Morrison as an independent trustee on July 6, 2026. Mr. Morrison brings experience as Chairman, CEO, and President of Regional Health Properties, Inc., and will receive standard non-employee trustee compensation. No other financial metrics or period comparisons are provided in this filing.

• · Mr. Morrison will serve until the next annual meeting of shareholders or until his earlier resignation, retirement, or removal.
• · The Board determined Mr. Morrison satisfies NYSE American independence requirements.
• · No arrangements or understandings exist between Mr. Morrison and any other person regarding his appointment.
• · No transactions involving Mr. Morrison require disclosure under Item 404(a) of Regulation S-K.

08-07-2026

Ultra Clean Holdings, Inc. (UCTT) announced the appointment of Michael Keogh as Chief Financial Officer, effective August 5, 2026, succeeding Sheri Savage. Keogh brings over 25 years of financial and operational leadership from Ford, Apple, Intel, and other firms, and will report to CEO James Xiao. The appointment is part of the company's UCT 3.0 strategy execution.

• · Keogh previously served as CFO of Ford Model e and Integrated Services, shaping Ford's EV strategy and supporting multi-billion-dollar joint ventures.
• · He led the financial turnaround at Bright Machines as CFO.
• · Earlier roles include senior finance leadership at Apple, Stanley Black & Decker, and Intel.
• · Keogh holds an MBA from Cornell University and a BA in Industrial Relations from UNC Chapel Hill.

08-07-2026

Byrna Technologies Inc. (BYRN) has entered into a definitive agreement to acquire substantially all assets of HERO Defense Systems, LLC for $1.25 million total consideration ($625,000 cash + $625,000 restricted stock) plus a performance-based royalty on future net sales. The strategic bolt-on acquisition adds compact everyday-carry personal defense products (HERO 2020 and AIIRO) to expand Byrna's product portfolio into smaller form factors and lower price points, with closing expected within 30 days. While the acquisition is small in absolute size, it is strategically positioned to broaden Byrna's addressable market and create a lower-friction entry point for new consumers, though integration risks and potential dilution from the restricted stock issuance remain considerations.

• · Transaction is structured as an asset purchase on a cash-free, debt-free basis.
• · Consideration includes a performance-based royalty tied to future net sales of HERO products and derivative products.
• · Restricted shares will be issued in a private placement under an exemption from the Securities Act of 1933 and will be subject to transfer restrictions.
• · HERO's founders are expected to provide transition and integration support following closing.
• · Byrna plans to evaluate opportunities to support HERO products through Byrna.com, Amazon, and retail merchandising.
• · The acquisition is subject to customary closing conditions and expected to close within approximately 30 days.
• · The filing includes forward-looking statements regarding integration, regulatory approvals, and market expansion risks.

08-07-2026

Longeveron Inc. issued special equity awards to its Executive Chairman on July 6, 2026, consisting of 500,000 RSUs for his role in the March 2026 financing transaction and an additional 100,000 RSUs plus 400,000 non-qualified stock options for continued service. All awards vest quarterly over three years starting October 1, 2026, and convert into Class B Common Stock (5 votes per share), which is convertible to Class A Common Stock. No financial results or period-over-period comparisons are provided in this filing.

• · The Executive Chairman (not named in filing) received the awards.
• · Class B Common Stock has 5 votes per share vs. Class A Common Stock's 1 vote per share.
• · Class B Common Stock is convertible at any time at the holder's option into Class A Common Stock.
• · The awards were approved by the Company's Compensation Committee.

08-07-2026

Alamo Group Inc. announced the appointment of Greg Lucas as Vice President, Corporate Controller and Chief Accounting Officer, effective on or before August 10, 2026. He will replace Agnes Kamps as principal accounting officer, while Ms. Kamps remains Executive Vice President and CFO. Mr. Lucas brings experience from Thermon Group, BNSF Railway, and Intertek, and will receive an annual base salary of $335,000 plus equity awards and incentive plan participation.

• · Mr. Lucas's employment is contingent upon passing pre-employment screenings.
• · No related party transactions were disclosed between Mr. Lucas and the Company.
• · Mr. Lucas holds a BBA in Accounting and Economics from East Texas Baptist University and an MBA from Texas A&M University.

08-07-2026

Alector, Inc. (ALEC) announced the termination of its collaboration agreement with GSK following the failure of two key clinical trials: the Phase 3 INFRONT-3 trial for latozinemab in frontotemporal dementia and the Phase 2 PROGRESS-AD trial for nivisnebart in early Alzheimer's disease. The GSK Agreement will terminate effective January 2, 2027. Additionally, the company repaid and terminated its loan agreement with Hercules Capital, repaying $10.4 million in principal plus accrued interest and charges.

• · The Phase 3 INFRONT-3 trial for latozinemab did not meet its clinical co-primary endpoint (announced October 21, 2025).
• · The Phase 2 PROGRESS-AD trial for nivisnebart was discontinued after an interim futility analysis (announced April 29, 2026).
• · The GSK Agreement termination is effective 180 days from July 6, 2026, i.e., January 2, 2027.
• · The loan repayment included accrued interest and end-of-term and prepayment charges.

08-07-2026

Seres Therapeutics held its reconvened 2026 Annual Meeting on July 8, 2026, where stockholders approved all five proposals, including the election of three Class II directors, ratification of PricewaterhouseCoopers as auditor, advisory approval of executive compensation, and an amendment to the 2025 Incentive Award Plan to increase authorized shares by 900,000. The meeting had a quorum of 4,985,176 shares (51.75% of outstanding stock), but the relatively high number of votes against or withheld on several proposals indicates some shareholder dissent.

• · The meeting had been adjourned from June 9, 2026 due to lack of quorum.
• · Broker non-votes totaled 868,715 on all proposals except the auditor ratification (which had 0 broker non-votes).
• · Proposal 3 (advisory say-on-pay) received 3,374,813 FOR, 620,353 AGAINST, and 121,295 abstentions – a notable 15.5% against vote.
• · Proposal 4 (plan amendment) passed with 3,438,763 FOR vs. 597,484 AGAINST (14.8% against).
• · Proposal 5 (adjournment) was approved but not needed since Proposal 4 passed.

08-07-2026

MacroGenics, Inc. (MGNX) announced that board member Dr. Karen Ferrante has resigned for personal reasons, effective September 1, 2026. Her departure is not due to any disagreement with the company's operations, policies, or practices.

08-07-2026

Phoenix Energy One, LLC entered into an indenture on July 7, 2026, to issue up to $100,000,000 in Senior Subordinated Junior Lien Notes, registered under an effective S-1 filing. The Notes carry interest rates of 6.00% to 7.00% per annum, mature in 10 years, and are subordinated to the company's senior debt under the Fortress Credit Agreement. No financial performance or prior period data is provided in this filing.

• · The offering is registered on Form S-1 (File No. 333-296428) declared effective July 7, 2026.
• · Notes are secured on a junior basis, with the intercreditor agreement granting Fortress exclusive remedy rights over shared collateral until first lien obligations are discharged.
• · No subsidiary or affiliate guarantees the Notes.
• · Holders may request redemption on Set Put Dates at 100% of principal plus accrued interest, with notice required 30-45 days prior.
• · Covenant requires the company to maintain a Loan-to-Value Ratio of 1.00 to 1.00.
• · Events of default include a 60-day cure period for payment defaults and a 120-day cure period for other covenant breaches.

08-07-2026

Canadian Pacific Kansas City Limited (CP) entered into a Second Amending Agreement on July 6, 2026, extending the maturity dates of its credit facilities. The 5 Year Facility maturity was extended from June 25, 2030 to June 25, 2031, and the 2 Year Facility maturity was extended from June 25, 2027 to June 25, 2028. This amendment provides the company with additional long-term financial flexibility.

• · The Second Amending Agreement amends the third amended and restated credit agreement dated June 25, 2024.
• · The 5 Year Facility maturity was extended by one year to June 25, 2031.
• · The 2 Year Facility maturity was extended by one year to June 25, 2028.
• · The amendment was entered into by Canadian Pacific Railway Company (borrower), Canadian Pacific Kansas City Limited (covenantor), and Bank of Montreal (administrative agent).

08-07-2026

First Bancorp, Inc. (FNLC) announced the retirement of Tammy Plummer, Executive Vice President and Chief Information Officer, after a 41-year career at First National Bank. Brad Martin has been appointed as her successor, bringing over 17 years of financial services experience, most recently as SVP, Director of IT at another Maine-based institution. The transition is planned to ensure continuity, with no financial impact disclosed.

• · Tammy Plummer started as a Teller in 1985 and held roles including Data Processing Manager (1994), CTO (2003), CIO (2014), and EVP/CIO (2015).
• · Brad Martin most recently served as Senior Vice President, Director of Information Technology at another Maine-based financial institution.
• · The filing was made under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers).

08-07-2026

Tarsus Pharmaceuticals acquired iRenix Medical for $75 million in upfront consideration ($37.5M cash + $37.5M stock) plus up to $490 million in milestone payments, adding late-stage asset IRX-101 for reducing post-intravitreal injection pain and corneal toxicity. IRX-101 has positive Phase 2b/3 data showing a ~50% relative reduction in pain and ~25% reduction in corneal staining versus povidone-iodine, with an FDA-aligned Phase 3 program expected to start in H1 2027 with results in 2028. The deal targets the >11 million annual U.S. intravitreal injection market where no new FDA-approved ocular antiseptic has emerged in over 40 years, but carries significant development, regulatory, and commercial risk.

• · Phase 3 study expected to begin enrollment in H1 2027, results anticipated in 2028.
• · p-value for pain reduction: 0.0003; p-value for corneal staining: 0.0003.
• · Half of patients in IRX-101 group reported a pain score of zero.
• · Povidone-iodine is contraindicated in iodine-sensitive patients.
• · Tarsus to host investor conference call on July 8, 2026 at 1:30 p.m. PT / 4:30 p.m. ET.
• · Transaction advisors: Gunderson Dettmer for Tarsus; Piper Sandler (financial) and DLA Piper (legal) for iRenix.
• · Full merger agreement to be filed as an exhibit with Form 10-Q for quarter ending September 30, 2026.

08-07-2026

Voyager Technologies, Inc. entered into a Fourth Amendment to its Credit Agreement on July 6, 2026, increasing its revolving commitments by $50 million to a total of $500 million (as inferred from the existing $450 million base plus the incremental $50 million). The amendment was led by JPMorgan Chase as lead arranger and bookrunner, and required consent from lenders representing the required majority. The company paid a 0.05% consent fee to participating lenders and satisfied standard conditions including legal opinions, solvency certificates, and no event of default.

• · The amendment was the fourth modification to the original Credit Agreement dated May 30, 2025, following prior amendments on September 18, 2025, October 22, 2025, and November 10, 2025.
• · Conditions included receipt of legal opinions, organizational documents, incumbency certificates, board resolutions, good standing certificates, and a solvency certificate.
• · No Default or Event of Default existed as of the effective date.
• · The amendment did not constitute a novation; existing obligations remained in full force.

08-07-2026

On July 7, 2026, ONCOLYTICS BIOTECH INC requested that its former auditor, Ernst & Young LLP (EY), provide a letter to the SEC regarding the company's statements about EY in connection with an accountant change. The filing includes EY's letter as Exhibit 16.1, indicating a change in the company's independent registered public accounting firm.

• · The filing is an 8-K under Items 4.01 (Changes in Registrant's Certifying Accountant) and 9.01 (Financial Statements and Exhibits).
• · The company requested EY's letter to the SEC on July 7, 2026.
• · The letter from EY is dated July 7, 2026, and is attached as Exhibit 16.1.
• · The filing was signed by CFO Kirk Look on July 8, 2026.

08-07-2026

Seritage Growth Properties entered into an amended and restated employment agreement with CEO Adam Metz on July 1, 2026, extending his term for an initial six months with a company option to extend another six months. The agreement increases his target annual bonus from $1,225,000 to $1,300,000 while maintaining his base salary at $1,100,000. The filing reflects a short-term retention arrangement with a modest bonus increase, but no other financial or operational changes were disclosed.

• · Employment agreement has an initial term of six months with a company option to extend for an additional six months.
• · If the extension option is not exercised, the bonus performance period is prorated to six months with a target of 50% of the full Target Bonus ($650,000).
• · No other changes were made to the terms and conditions of the employment agreement beyond the bonus increase and term structure.
• · The filing does not include any financial results, operational updates, or changes to the board of directors.

08-07-2026

NAPCO Security Technologies announced an executive leadership transition effective July 8, 2026: founder Richard Soloway moves from CEO to Executive Chairman, and President/COO Kevin Buchel becomes CEO and President. The change is intended to position the company for its next phase of growth, with Soloway remaining Chairman and focusing on strategic initiatives and innovation.

• · Richard Soloway founded NAPCO more than 55 years ago
• · Kevin Buchel has been with NAPCO for more than 25 years and served as President and COO for two years
• · The press release contains forward-looking statements regarding the transition and the Company's ability to increase revenue and profitability

08-07-2026

Presidio Production Company closed its $83 million acquisition of Canyon Creek assets from Vortus Investments, marking its entry into the Arkoma Basin and first use of its $1.0 billion ABS Warehouse Facility led by Goldman Sachs. The company expects to increase its annualized dividend from $1.35 to $1.50 per share, subject to board approval, and anticipates year-one free cash flow yield and levered returns both exceeding 20%. However, the acquired assets have an 11% annual decline rate, and the company issued 1,962,240 new shares to sellers, which may dilute existing shareholders.

• · Acquisition funded via $55M draw on $1.0B ABS Warehouse Facility led by Goldman Sachs.
• · Citizens Bank joined the facility with 40% participation.
• · Acquired assets: 55 producing wells, 21 MMcfe/d net PDP production (70% natural gas, 30% NGLs), 11% annual decline.
• · Estimated Proved Developed Producing PV-10 of $100M and reserves of 100 Bcfe.
• · 1,962,240 new Class A shares issued to sellers.
• · Detailed hedge positions provided for oil, natural gas, basis, and NGLs through 2029 and beyond.

08-07-2026

Invitation Homes Inc. (INVH) announced the closing of an underwritten public offering of $500 million aggregate principal amount of 4.950% Senior Notes due 2032 by its operating partnership. The notes are fully and unconditionally guaranteed by the parent company and other guarantors, and were issued at 98.691% of par. The issuance represents a refinancing or capital markets activity with no associated period-over-period performance data.

• · Notes mature on February 1, 2032.
• · Interest payable semi-annually on February 1 and August 1, commencing February 1, 2027.
• · Prior to January 1, 2032 (Par Call Date), the issuer may redeem at the greater of 100% of principal plus accrued interest or the present value of remaining payments discounted at Treasury Rate plus 15 basis points.
• · On or after the Par Call Date, the issuer may redeem at 100% of principal plus accrued interest.
• · Events of default include 30-day interest payment default, principal payment default, failure to comply with covenants (60-day cure), cross-default on other debt over $50 million (60-day cure), and bankruptcy of the issuer or any guarantor.
• · The offering was made under an effective shelf registration statement filed June 14, 2024 (Registration Nos. 333-280210, 333-280210-01, 333-280210-02, 333-280210-03) and a prospectus supplement dated June 30, 2026.
• · The notes are senior unsecured obligations and are effectively subordinated to all existing and future secured indebtedness and liabilities of non-guarantor subsidiaries.

08-07-2026

Netcapital Inc. CEO Todd Violette provided a shareholder update outlining a strategic shift from a standalone Regulation Crowdfunding portal to a comprehensive ecosystem integrating education, advisory, data analytics, and broker-dealer services. The company is developing 'Project Orion,' a private AI operating environment, and is actively evaluating data center acquisitions to support its technology infrastructure. No financial results or specific performance metrics were disclosed, and the update emphasized that these initiatives are in early evaluation stages with no definitive agreements.

• · The company is evaluating acquisitions of data center assets and infrastructure to support AI computing requirements, but these are in early evaluation stages and subject to board approval and regulatory processes.
• · Netcapital operates a regulated funding portal and a FINRA-registered broker-dealer, which are viewed as the foundation for a larger ecosystem.
• · The update explicitly states it is not a financial earnings call and contains forward-looking statements with no obligation to update.

08-07-2026

Sadot Group Inc. entered into two Debt Settlement and Share Issuance Agreements on July 7, 2026, to settle outstanding indebtedness of $1,876,500 to Cedar Advance LLC and $1,482,912.50 to Agile Capital Funding, LLC and Agile Lending LLC by issuing 45,000 shares of common stock to each creditor (90,000 shares total). No cash consideration was paid; the shares represent approximately 9% of outstanding common stock post-issuance. The settlements were conducted under exemptions from registration under the Securities Act.

• · The Settlement Agreements are governed by the laws of the State of Nevada.
• · The shares were issued in reliance on exemptions under Section 3(a)(9) and/or Section 4(a)(2) of the Securities Act.
• · Each creditor represented that it is an accredited investor.
• · The settlement shares have not been registered under the Securities Act and are subject to restrictions on resale.

08-07-2026

374Water Inc. appointed Charles Weiser as CFO effective July 1, 2026, with an annual base salary of $225,000 (deferred until September 1, 2026), a $25,000 signing bonus, and equity grants of 150,000 stock options and 125,000 RSUs. Concurrently, Interim CFO Adrienne Anderson resigned but will continue providing financial consulting services. The appointment fills a key leadership role, though the salary deferral and bonus contingency on capitalization signal ongoing cash constraints.

• · Charles Weiser, age 67, has been a board member since December 29, 2025, and will continue on the board while serving as CFO.
• · Weiser's base salary will not commence until September 1, 2026; no salary for July 1 – August 31, 2026.
• · The $25,000 signing bonus accrues July 1, 2026, but is payable only when the Company is properly capitalized.
• · Equity grants: 25% vest immediately on grant date; remaining 75% vest in 12 equal quarterly installments starting October 1, 2026.
• · Upon a change of control, 50% of unvested equity vests immediately; if terminated without cause or resignation for good reason within 12 months post-change, all remaining unvested shares vest.
• · Severance includes 6 months base salary, continued health coverage, pro-rated bonus, and 6 months accelerated equity vesting.
• · Adrienne Anderson resigned as Interim CFO effective July 1, 2026, but will continue providing consulting services on SEC reporting, compliance, and corporate finance.

08-07-2026

Contango ORE, Inc. amended its credit facility to convert the remaining 15,000 ounces of hedged gold into $33.0M of debt, eliminating the ceiling on future gold price exposure. The interest rate was reduced from ~8.9% to ~7.40%, and the total principal increased from $12.6M to $46.3M with scheduled repayments through June 2027. While the company is bullish on gold and expects a record 2027, the debt load has significantly increased and the Manh Choh mine is in a transitional phase between pits.

• · The company paid $715,000 to purchase 15,000 put contracts with a $3,100/oz strike price as a price protection strategy.
• · Manh Choh mine is transitioning from North Pit to South Pit, with higher-grade campaigns expected to finish 2026.
• · The company retains flexibility to repay the debt at any time and is focused on paying down the credit facility ahead of schedule.
• · No restructuring fee was incurred for the amendment.

08-07-2026

FutureTech II Acquisition Corp. (FTIIU) disclosed in an 8-K filing that its previously issued financial statements for multiple periods (Q3 2024, FY 2024, Q1 2025, Q2 2025) contain errors and must be restated. The restatements involve adjustments to earnings per share, tax amounts, common stock redemption values, and sponsor-related trust amounts. Additionally, management identified a material weakness in internal controls over financial reporting, including ineffective reconciliation and journal entry review processes, and has begun remediation efforts such as engaging a new external advisor and implementing new software modules.

• · The restatement covers four sets of financial statements: Q3 2024 (unaudited interim), FY 2024 (audited), Q1 2025 (unaudited interim), and Q2 2025 (unaudited interim).
• · The corresponding periodic reports (Q3 2024 10-Q, FY 2024 10-K, Q1 2025 10-Q, Q2 2025 10-Q) should no longer be relied upon.
• · Material weakness in internal control over financial reporting was identified as of December 31, 2024 and December 31, 2025.
• · Remediation efforts include engaging a new external advisor and implementing additional Quickbooks Online modules.
• · The company plans to amend the Q3 2024 10-Q in the Q3 2025 10-Q filing, and amend the FY 2024 10-K, Q1 2025 10-Q, and Q2 2025 10-Q in the FY 2025 10-K.

08-07-2026

Vistance Networks completed the sale of its RUCKUS Networks business to Belden Inc. for $1.846 billion in cash on July 1, 2026. The company expects to distribute a significant portion of net proceeds to shareholders as a special distribution within 60 days. However, the remaining business (continuing operations) has been unprofitable in recent years, with pro forma operating losses of $29.8 million in FY2025 and $290.6 million in FY2024, contrasting with the strong contribution of RUCKUS.

• · RUCKUS contributed $173.4M (36.7%) of historical Vistance Networks revenue in Q1 2026 and $686.8M (35.6%) in FY2025.
• · Pro forma continuing operations had operating income of only $0.6M in Q1 2026 vs historical $23.7M, and an operating loss of $29.8M in FY2025.
• · Vistance Networks expects to recognize the sale as discontinued operations in its Q2 2026 10-Q.
• · Pro forma balance sheet shows total stockholders' equity of $5,546.0M, up from $4,594.5M historical due to retained earnings adjustment.
• · No autonomous entity adjustments or synergy/dis-synergy adjustments were reflected in the pro forma statements.
• · The company had large income tax benefits in continuing operations: $190.3M in Q1 2026 and $297.5M in FY2025, primarily from valuation allowance releases.

08-07-2026

GoPro announced that founder and CEO Nicholas Woodman will provide $20 million in financing through senior secured notes and warrants, a move approved by an independent board committee. The financing reflects Woodman's confidence in GoPro's opportunities, but the company continues to evaluate strategic alternatives announced on May 11, 2026, and faces risks including potential dilution and liquidity concerns.

• · The financing is subject to certain closing conditions.
• · The independent committee evaluated a range of financing options and concluded this structure offered the most favorable terms.
• · The strategic alternatives review process was announced on May 11, 2026, and continues to progress.
• · Risks include potential dilutive effect of warrants and other equity-linked securities on existing stockholders.
• · The financing is a related-party transaction, which carries inherent risks.

08-07-2026

Cantor Equity Partners II, Inc. (CEPT) completed its business combination with Securitize, Inc. on July 1, 2026, resulting in CEPT merging into a subsidiary of newly formed Pubco (Securitize Holdings, Inc.). As a result, CEPT's Class A ordinary shares were delisted from Nasdaq and Pubco's common stock began trading on the NYSE under the ticker 'SECZ' on July 2, 2026. However, a significant 6,842,508 shares (approximately 23% of the pre-merger shares) were redeemed by holders, and the PIPE financing raised only $197 million of the originally targeted $225 million.

• · The business combination was originally announced on October 27, 2025.
• · CEPT's Class A ordinary shares were delisted from Nasdaq effective July 2, 2026.
• · CEPT intends to file a Form 15 to deregister its shares and suspend reporting obligations.
• · All former officers and directors of CEPT ceased their positions upon the merger.
• · The PIPE shares were issued in reliance on the Section 4(a)(2) exemption from registration.

08-07-2026

BellRing Brands (NYSE:BRBR) announced the appointment of Michael Axelrod as its next President and CEO, effective July 29, 2026, succeeding Darcy Davenport who is retiring. Axelrod brings over 30 years of CPG experience, most recently as CEO of Snak King, and will also join the Board of Directors. The company reported over $2.3 billion in sales under Davenport's tenure, but faces the challenge of maintaining growth momentum amid strong consumer demand for protein, with Premier Protein holding the #1 ready-to-drink protein brand position.

• · Axelrod will also be appointed to the company's Board of Directors.
• · Davenport will stay on in a senior advisory capacity to ensure a smooth transition.
• · Axelrod holds an honors bachelor's degree from University of Western Ontario Ivey Business School and an MBA from Northwestern University Kellogg School of Management.
• · The company's brands are distributed in over 90 countries across club, mass, food, eCommerce, specialty, drug and convenience channels.

08-07-2026

Nocera, Inc. announced a 1-for-30 reverse stock split effective July 6, 2026, to increase its share price and maintain Nasdaq listing compliance. The split reduces outstanding shares from 46,495,187 to approximately 1,549,956, while proportionate ownership remains unchanged. The move supports Nocera's transformation into a diversified technology holding company, but the high split ratio signals ongoing stock price weakness and potential delisting risk.

• · The reverse stock split was authorized by stockholders at the January 12, 2026 annual meeting under Proposal No. 4, authorizing a range between 1-for-5 and 1-for-100.
• · The Board selected the 1-for-30 ratio on June 25, 2026, within the stockholder-approved range.
• · No fractional shares will be issued; holders receive cash equal to fractional share interest multiplied by Nasdaq closing price on the last trading day before effectiveness.
• · Proportionate adjustments will be made to per share exercise prices and numbers of shares issuable upon exercise of all outstanding stock options and warrants, and to restricted stock units and equity incentive plan reserves.
• · New CUSIP number following the reverse split: 655186609.
• · The Company intends to use the higher share price to facilitate acquisitions, partnerships, and investments under its holding company strategy, including the previously announced minority equity investment in CampaignPulse.ai.

08-07-2026

Greenland Mines Ltd. (formerly Klotho Neurosciences, Inc.) terminated its At-the-Market Sales Agreement with A.G.P./Alliance Global Partners effective July 4, 2026. The termination was at the company's right with no penalties incurred, and no shares remain available for sale under the agreement. This filing also reflects the company's name changes from Klotho Neurosciences, Inc. to Greenland Mines Ltd. as of October 1, 2024.

• · The company is an emerging growth company and has elected not to use the extended transition period for complying with new or revised financial accounting standards.
• · The company's common stock trades under the symbol GRML on Nasdaq, and its warrants trade under GRMLW.
• · The company has undergone multiple name changes: from Redwoods Acquisition Corp. (Jan 2022) to ANEW Medical, Inc. (Jun 2024) to Klotho Neurosciences, Inc. (Oct 2024) to Greenland Mines Ltd. (current).

08-07-2026

Charles & Colvard, Ltd. completed the sale of its assets to AJS Creations, Inc. for $2.7M in cash, following a bankruptcy auction on June 22, 2026. The original stalking horse bidder, Jewelry Design Partners LLC (JDP), had agreed to acquire the assets for $1.5M (subject to a credit bid), but AJS's overbid of $2.7M was deemed the highest and best. The JDP Purchase Agreement was terminated, and the company paid JDP a $45,000 break-up fee. The company cautions that common stock holders may experience a significant or complete loss on their investment.

• · The bankruptcy auction was held on June 22, 2026, with AJS designated as the successful bidder and Light & Star as the back-up bidder.
• · The Bankruptcy Court for the Eastern District of North Carolina approved the AJS Transaction on July 1, 2026.
• · The company is currently unable to prepare pro forma financial information without unreasonable effort or expense.
• · The company files monthly operating reports with the Bankruptcy Court, which are limited in scope and not intended for investment decisions.

08-07-2026

ReposiTrak, Inc. entered a stock purchase agreement with William Bartels to acquire 4,016,812 shares of SPAR Group, Inc. for $0.70 per share, totaling $2,811,768. The deal includes a $100,000 non-refundable deposit, a $139,883 closing payment, and a $2,571,885 promissory note. ReposiTrak retains the right to terminate the agreement for any reason before closing, in which case the deposit is kept by the seller as liquidated damages.

• · The agreement includes a no-public-announcement clause until after the closing or as required by securities laws.
• · The promissory note accelerates upon the seller's death, with proceeds payable to heirs within 60 days of proof of death.
• · ReposiTrak explicitly disclaims intent or ability to control SPAR Group, Inc. post-purchase.
• · The agreement is governed by Utah law, with exclusive jurisdiction in Utah courts and a jury trial waiver.
• · Seller retains termination fee (deposit) as liquidated damages if buyer terminates for any reason.